AUPH - Company ID 0001600620
The table below shows Aurinia Pharmaceuticals Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $80.16M | $83.40M | $48.76M | $94.09M | $231.64M | $272.35M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | $45.69M | $39.23M | $39.70M | $24.75M | $19.33M | $13.93M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $491.97M |
| $446.60M |
| $424.80M |
| $442.54M |
| $513.32M |
| $419.43M |
| Property, plant & equipment | $2.11M | $2.73M | $3.35M | $3.65M | $4.42M | $4.79M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $751.59M | $550.64M | $548.06M | $470.86M | $543.37M | $463.66M |
| Accounts payable | $3.31M | $5.19M | - | - | - | - |
| Total current liabilities | $93.72M | $97.76M | $77.19M | $46.11M | $40.65M | $32.00M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $170.26M | $173.17M | $170.11M | $65.42M | $64.28M | $55.91M |
| Retained earnings | -$649.37M | -$936.57M | -$942.32M | -$864.30M | -$756.12M | -$575.16M |
| Total equity | $581.33M | $377.48M | $377.95M | $405.44M | $479.09M | $407.75M |